We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Pergolide and cabergoline were associated with increased risk for newly diagnosed cardiac valve regurgitation.
- Authors
Schade, R.; Andersohn, F.; Suissa, S.; Haverkamp, W.; Garbe, E.
- Abstract
The article presents a study which examines whether dopamine agonists increase the risk of newly diagnosed cardiac valve regurgitation in patients taking anti-Parkinsonian drugs. Results revealed that the use of pergolide and cabergoline has led to higher risk of newly diagnosed cardiac valve than dopamine agonists. It is concluded that dopamine agonists anti-Parkinsonian drugs, pergolide and cabergoline were associated with the increased risk for cardiac valve regurgitation.
- Subjects
MEDICAL research; HEART valve diseases; DOPAMINE agonists; ANTIPARKINSONIAN agents; DRUG side effects; PATIENTS
- Publication
ACP Journal Club, 2007, Vol 146, Issue 3, p75
- ISSN
1056-8751
- Publication type
Article